Health Care: Drugs

Bristol-Myers Squibb Company (BMY: NYSE)

$44.06 0.30 | 0.69%
05/21/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 17.62B 21.24B 19.48B 18.81B
Cost of Sales 3.93B 4.80B 4.53B 4.43B
Gross Operating Profit 13.69B 16.45B 14.95B 14.38B
Selling, General, and Administrative Expenses 4.22B 4.20B 3.70B 4.08B
Research & Development 3.90B 3.84B 3.57B 3.65B
Operating Income before D & A (EBITDA) 4.77B 7.45B 6.70B 5.51B
Depreciation & Amortization 681.00M 801.00M 744.00M 707.00M
Interest Income 0.00 91.00M 75.00M 54.00M
Other Income - Net 79.00M 504.00M -18.00M 511.00M
Special Income / Charges -1.83B 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 2.52B 7.13B 6.22B 5.79B
Interest Expense 182.00M 145.00M 145.00M 184.00M
Pre-Tax Income 2.34B 6.98B 6.07B 5.60B
Income Taxes -161.00M 1.72B 1.56B 1.18B
Minority Interest 541.00M 1.55B 1.41B 1.25B
Net Income From Continuing Operations 2.50B 5.26B 4.51B 4.42B
Net Income From Discontinued Operations 0.00 0.00 0.00 7.44B
Net Income From Total Operations 2.50B 5.26B 4.51B 11.86B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 1.96B 3.71B 3.10B 10.61B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 4.33B 5.38B 4.63B 4.56B
Preferred Dividends
Net Income Available To Common 2.50B 5.26B 4.51B 4.42B
Basic EPS from Continuing Ops. 1.17 2.18 1.80 1.63
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.17 2.18 1.80 1.63
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 3.72
Basic EPS, Total 1.17 2.18 1.80 5.35
Basic Normalized Net Income/Share 2.03 2.23 1.85 1.68
EPS fr Continuing Ops. 1.16 2.16 1.79 1.63
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.16 2.16 1.79 1.63
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 3.71
EPS, Total 1.16 2.16 1.79 5.34
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 2.01 2.21 1.83 1.68
Dividends Paid per Share 1.36 1.32 0.96 1.25

Portfolios with BMY

View All

Latest BMY Headlines from TheStreet

More Financial News for BMY

Press Releases for BMY

See All Press Releases

Partner Headlines for BMY

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter